Effect of aldehydes derived from oxidative deamination and oxidative stress on beta-amyloid aggregation; pathological implications to Alzheimer's disease
- PMID: 17401529
- DOI: 10.1007/s00702-007-0697-5
Effect of aldehydes derived from oxidative deamination and oxidative stress on beta-amyloid aggregation; pathological implications to Alzheimer's disease
Abstract
Formaldehyde and methylglyoxal are generated via deamination from methylamine and aminoacetone respectively catalyzed by semicarbazide-sensitive amine oxidase (SSAO). Malondialdehyde (MDA) and 4-hydroxynonenal (HNE) are end products of lipid peroxidation due to oxidative stress. These aldehydes are capable of inducing protein cross-linkage. Elevated levels of aldehydes were found in Alzheimer's disease (AD). These reactive metabolites may potentially play important roles in beta-amyloid (Abeta) aggregation related to the pathology of AD. In the present study thioflavin-T (ThT) fluorometry, an immuno-dot-blot assay and atomic force microscopy (AFM) were employed to reveal the effect of aldehydes on Abeta aggregation in vitro. The target on Abeta for interaction with formaldehyde was identified. The results support the involvement of endogenous aldehydes in amyloid deposition related to AD.
Similar articles
-
Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis.J Neurochem. 2006 Dec;99(5):1413-24. doi: 10.1111/j.1471-4159.2006.04181.x. J Neurochem. 2006. PMID: 17074066
-
Deamination of methylamine and aminoacetone increases aldehydes and oxidative stress in rats.Life Sci. 1998;63(23):2049-58. doi: 10.1016/s0024-3205(99)80001-0. Life Sci. 1998. PMID: 9839528
-
Evidence for in vivo scavenging by aminoguanidine of formaldehyde produced via semicarbazide-sensitive amine oxidase-mediated deamination.J Pharmacol Exp Ther. 2007 Sep;322(3):1201-7. doi: 10.1124/jpet.107.124123. Epub 2007 Jun 27. J Pharmacol Exp Ther. 2007. PMID: 17596537
-
Physiological and pathological implications of semicarbazide-sensitive amine oxidase.Biochim Biophys Acta. 2003 Apr 11;1647(1-2):193-9. doi: 10.1016/s1570-9639(03)00101-8. Biochim Biophys Acta. 2003. PMID: 12686132 Review.
-
HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.Free Radic Biol Med. 2017 Oct;111:262-269. doi: 10.1016/j.freeradbiomed.2016.10.508. Epub 2016 Nov 10. Free Radic Biol Med. 2017. PMID: 27838436 Free PMC article. Review.
Cited by
-
Catechol-Type Flavonoids from the Branches of Elaeagnus glabra f. oxyphylla Exert Antioxidant Activity and an Inhibitory Effect on Amyloid-β Aggregation.Molecules. 2020 Oct 23;25(21):4917. doi: 10.3390/molecules25214917. Molecules. 2020. PMID: 33114256 Free PMC article.
-
SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.Int J Mol Sci. 2021 Mar 25;22(7):3365. doi: 10.3390/ijms22073365. Int J Mol Sci. 2021. PMID: 33805974 Free PMC article. Review.
-
The Antioxidant Cofactor Alpha-Lipoic Acid May Control Endogenous Formaldehyde Metabolism in Mammals.Front Neurosci. 2017 Dec 1;11:651. doi: 10.3389/fnins.2017.00651. eCollection 2017. Front Neurosci. 2017. PMID: 29249928 Free PMC article.
-
Copper in the brain and Alzheimer's disease.J Biol Inorg Chem. 2010 Jan;15(1):61-76. doi: 10.1007/s00775-009-0600-y. Epub 2009 Oct 28. J Biol Inorg Chem. 2010. PMID: 19862561 Review.
-
Formaldehyde, Epigenetics, and Alzheimer's Disease.Chem Res Toxicol. 2019 May 20;32(5):820-830. doi: 10.1021/acs.chemrestox.9b00090. Epub 2019 Apr 19. Chem Res Toxicol. 2019. PMID: 30964647 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous